Items where authors include "Patel, S"

Article

Hardt, K, Vandebosch, A, Sadoff, J et al. (285 more authors) (2022) Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Infectious Diseases, 22 (12). pp. 1703-1715. ISSN 1473-3099

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Polašek, O, Wazny, K, Adeloye, D et al. (65 more authors) (2022) Research priorities to reduce the impact of COVID-19 in low- and middle-income countries. Journal of Global Health, 12. 09003. ISSN 2047-2978

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Ahmed, WUR, Bhatia, S, McLean, KA et al. (4545 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS Open, 6 (1). zrab150. ISSN 2474-9842

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

Turner, EL, Platt, AC, Gallis, JA et al. (82 more authors) (2021) Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review. The Lancet Global Health, 9 (8). e1163-e1168. ISSN 2214-109X

Turner, EL, Platt, AC, Gallis, JA et al. (82 more authors) (2021) Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review. The Lancet Global Health, 9 (8). e1163-e1168. ISSN 2214-109X

Smith, ME, Hardman, JC, Mehta, N et al. (83 more authors) (2021) Acute otitis externa : consensus definition, diagnostic criteria and core outcome set development. PLoS ONE, 16 (5). e0251395. ISSN 1932-6203

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

McMaster, D, Courtenay, M, Santucci, C et al. (50 more authors) (2020) Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students. JAC-Antimicrobial Resistance, 2 (4). dlaa096. ISSN 2632-1823

McMaster, D, Courtenay, M, Santucci, C et al. (20 more authors) (2020) Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical students. JAC-Antimicrobial Resistance, 2 (4). dlaa096. ISSN 2632-1823

Lee, MJ, Drake, TM, Sayers, AE et al. (532 more authors) (2020) Outcomes of obstructed abdominal wall hernia: results from the UK national small bowel obstruction audit. BJS Open, 4 (5). pp. 924-934. ISSN 2474-9842

Drake, TM, Lee, MJ orcid.org/0000-0001-9971-1635, Sayers, AE et al. (533 more authors) (2019) Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction. European Journal of Surgical Oncology, 45 (12). pp. 2319-2324. ISSN 0748-7983

Wei, W, Tuna, S, Keogh, MJ et al. (426 more authors) (2019) Germline selection shapes human mitochondrial DNA diversity. Science, 364 (6442). 749-+. ISSN 0036-8075

Dennis, M, Mead, G, Forbes, J et al. (1294 more authors) (2019) Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. The Lancet, 393 (10168). pp. 265-274. ISSN 0140-6736

Murray, CJL, Callender, CSKH, Kulikoff, XR et al. (985 more authors) (2018) Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392 (10159). pp. 1995-2051. ISSN 0140-6736

Kluetz, PG, Kanapuru, B, Lemery, S et al. (25 more authors) (2018) Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in Health, 21 (6). pp. 742-747. ISSN 1098-3015

Shillitoe, B, Bangs, C, Guzman, D et al. (30 more authors) (2018) The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clinical and Experimental Immunology, 192 (3). pp. 284-291. ISSN 0009-9104

Kumar, V orcid.org/0000-0002-8825-3517, Patel, S and Jain, R (2018) New structural classes of antituberculosis agents. Medicinal Research Reviews, 38 (2). pp. 684-740. ISSN 0198-6325

Higginbotham, A orcid.org/0000-0001-5211-9933, Stubley, P G, Comley, A J et al. (10 more authors) (2016) Inelastic response of silicon to shock compression. Scientific Reports. 24211. ISSN 2045-2322

Proceedings Paper

Smith, C, Chadwick, H orcid.org/0000-0002-8022-5490, Farinha, C et al. (22 more authors) (2023) P136 ECFS syllabuses for the multidisciplinary team and wider field: a guide for comprehensive education. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S106-s106.